Compound Detail
CHEMBL12856
INAMRINONE 💊 Approved Drug
Enter ChEMBL ID:
Free Research Context
This compound will appear in recent viewed items on the research home for this browser.
Research home
View demo workspace
💊 Approved Drug
Basic Information
| ChEMBL ID | CHEMBL12856 |
| Name | INAMRINONE |
| Phase | Approved |
| Structure Type | MOL |
| InChI Key | RNLQIBCLLYYYFJ-UHFFFAOYSA-N |
| Therapeutic | ✓ Yes |
11
Targets
32
Activities
3
Assay Types
6
PK Parameters
20
Publications
12
Known Names
1
Indications
Molecular Properties
187.2
MW (Da)
1.02
ALogP
3
HBA
2
HBD
71.8
PSA (Ų)
0.70
QED
0
Ro5 Violations
1
Rot. Bonds
Drug Information
| Molecule Type | Small molecule |
| First Approval | 1984 |
| Availability | Prescription |
| Chirality | Achiral |
Indications
Cardiovascular Diseases
ATC Classification
C01CE01
amrinone
Level 1: CARDIOVASCULAR SYSTEM
Level 2: CARDIAC THERAPY
Activity Summary
IC50 26 meas. best 5.32
EC50 3 meas. best 5.13
Ki 3 meas. best 4.23
Target Activity Profile
| Target | Type | Best pChEMBL | Mean pChEMBL | Best (nM) | # Data |
|---|---|---|---|---|---|
| Phosphodiesterase; PDE3 & PDE4 CHEMBL2095153 | IC50 | 5.32 | 5.32 | 4800.0 | 1 |
| Cavia porcellus CHEMBL369 | EC50 | 5.13 | 5.13 | 7400.0 | 1 |
| Homo sapiens CHEMBL372 | IC50 | 4.82 | 4.56 | 15000.0 | 2 |
| Phosphodiesterase 3 CHEMBL2094125 | IC50 | 4.8 | 4.5056 | 16000.0 | 9 |
| Aorta CHEMBL613606 | EC50 | 4.77 | 4.66 | 17000.0 | 2 |
| Phosphodiesterase 4 CHEMBL2093863 | IC50 | 4.39 | 4.39 | 41000.0 | 1 |
| Unchecked CHEMBL612545 | IC50 | 4.3 | 4.3 | 50000.0 | 1 |
| Aurora kinase B/Inner centromere protein CHEMBL3430907 | Ki | 4.23 | 4.23 | 59300.0 | 1 |
| 1-acylglycerol-3-phosphate O-acyltransferase ABHD5/Perilipin-5 CHEMBL3885501 | IC50 | 4.1 | 4.1 | 78816.0 | 1 |
| Dual specificity protein kinase TTK CHEMBL3983 | Ki | 4.09 | 4.09 | 80800.0 | 1 |
| Aurora kinase A CHEMBL4722 | Ki | 3.4 | 3.4 | 393900.0 | 1 |
Pharmacokinetic Data
| Parameter | Value | Units | Species |
|---|---|---|---|
| CL | 8.9 | mL.min-1.kg-1 | Homo sapiens |
| CL | 8.9 | mL.min-1.kg-1 | Homo sapiens |
| F | 80.0 | % | Homo sapiens |
| Fu | 0.89 | - | Homo sapiens |
| MRT | 2.4 | hr | Homo sapiens |
| T1/2 | 2.0 | hr | Homo sapiens |
Activity Data Samples
Top measurements by pChEMBL value
Literature References
| PubMed | DOI | Target Context | # Activities |
|---|---|---|---|
| 3599022 | 10.1021/jm00390a007 | Canis familiaris | 20 |
| 8355248 | 10.1021/jm00069a005 | Cavia porcellus | 18 |
| 16472241 | 10.2174/1570163043334794 | Hepatotoxicity | 18 |
| 21051535 | 10.1124/dmd.110.034629 | ADMET | 15 |
| 22194678 | 10.1371/journal.pcbi.1002310 | Hepatotoxicity | 14 |
| 8809156 | 10.1021/jm9508649 | Cavia porcellus | 14 |
| 15646539 | 10.1016/s0399-8320(04)95062-2 | Unchecked | 11 |
| 15646539 | 10.1016/s0399-8320(04)95062-2 | NON-PROTEIN TARGET | 8 |
| 2536438 | 10.1021/jm00122a011 | Canis familiaris | 5 |
| 2864447 | 10.1021/jm00148a006 | Canis familiaris | 5 |
| 4009593 | 10.1021/jm00383a006 | Felis catus | 4 |
| - | 10.6019/CHEMBL4495565 | SARS-CoV-2 | 4 |
| 18426954 | 10.1124/dmd.108.020479 | ADMET | 4 |
| 2536438 | 10.1021/jm00122a011 | Homo sapiens | 4 |
| 3039135 | 10.1021/jm00391a026 | Canis familiaris | 4 |
| 3033241 | 10.1021/jm00388a014 | Canis familiaris | 3 |
| 20014752 | 10.1021/tx900326k | Hepatotoxicity | 3 |
| 3701782 | 10.1021/jm00155a009 | Canis familiaris | 3 |
| 2153209 | 10.1021/jm00163a052 | Phosphodiesterase 4 | 3 |
| 3027335 | 10.1021/jm00385a001 | Phosphodiesterase; PDE3 & PDE4 | 3 |
Data from ChEMBL 36 via Core Engine